SHORT MINI-FUTURE - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000VU4WSQ2

Delayed Deutsche Boerse AG 11:32:10 22/05/2024 pm IST
12.56 EUR +8.28% Intraday chart for SHORT MINI-FUTURE - FRESENIUS MEDICAL CARE
Current month-2.10%
1 month-5.35%
Date Price Change
22/24/22 12.56 +8.28%
21/24/21 11.6 +7.81%
20/24/20 10.76 -1.56%
17/24/17 10.93 -0.09%
16/24/16 10.94 +2.53%

Delayed Quote Deutsche Boerse AG

Last update May 22, 2024 at 11:32 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VU4WSQ
ISINDE000VU4WSQ2
Date issued 16/03/2023
Strike 51.22
Maturity Unlimited
Parity 1 : 1
Emission price 17.28
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 21.29
Lowest since issue 2.72
Spread 0.12
Spread %0.95%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.75 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.82%
Consensus